Presently, the company is looking for partners to drive clinical drug development of its lead product, ST266, in ophthalmic indications. Noveome Biotherapeutics, Inc. is a clinical-stage ...
ST266 is a first-of-its-kind, multi-targeted, non-cellular platform biologic with the potential to improve patients’ outcomes across a range of challenging diseases and conditions in ...
This image shows myelin (blue) in the optic nerve of a normal mouse (top), a mouse with optic neuritis (middle), and an optic neuritis mouse treated with ST266 (bottom). Disclaimer: AAAS and ...
Technology Networks recently spoke with William J. Golden, Noveome Biotherapeutics’ Founder, Chairman and CEO, who explains the underlying basis for investigating ST266’s potential against COVID-19.
Technology Networks recently spoke with William J. Golden, Noveome Biotherapeutics’ Founder, Chairman and CEO, who explains the underlying basis for investigating ST266’s potential against COVID-19.
A polecat, once on the brink of extinction, has been spotted on a university's campus for the first time. Nottingham Trent University said the creature, similar to a ferret, was caught on camera ...
The Polecats formed in 1977. The original line-up was Tim Worman (a.k.a Tim Polecat, vocalist), Martin "Boz" Boorer, (guitarist and vocalist), Phil Bloomberg (bassist), and Chris Hawkes (drummer ...
A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...